Arrowhead Pharmaceuticals (ARWR) FCF Margin (QoQ) (2012 - 2026)

Arrowhead Pharmaceuticals (ARWR) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arrowhead Pharmaceuticals 11.98 Bn 10.18 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10,675.00
Dec 31, 2025 -372.00
Sep 30, 2025 52,033.00
Jun 30, 2025 -59,519.00
Mar 31, 2025 603,672.00
Dec 31, 2023 -408,998.00
Sep 30, 2023 -135,041.00
Jun 30, 2023 22,879.00
Mar 31, 2023 14,262.00
Dec 31, 2022 13,834.00
Sep 30, 2022 -7,956.00
Jun 30, 2022 -27,993.00
Mar 31, 2022 28,268.00
Dec 31, 2021 -16,031.00
Sep 30, 2021 -1,110.00
Jun 30, 2021 -85,547.00
Mar 31, 2021 98,514.00
Dec 31, 2020 -3,054.00
Sep 30, 2020 -4,231.00
Jun 30, 2020 267.00